In addition to the Center of Pharmacogenomics, the Department of Pharmacotherapy and Translational Research has a variety of ongoing research projects.
|Areas of specialization||Collaborators|
|Drug response, drug-drug interactions, drug transporters and drug metabolism enzymes||Dr. Julio Duarte, Dr. Reginald Frye, and Dr. John Markowitz|
|Oncology – Leukemia and solid tumors||Dr. Jatinder Lamba|
|Oncology/Hematology||Dr. David DeRemer|
|Cardiovascular Disease, hypertension, metabolic syndrome and diabetes||Dr. Meghan Arwood, Dr. Larisa Cavallari, Dr. Rhonda Cooper-Dehoff, Dr. Yan Gong, Dr. Julie A. Johnson, Dr. Taimour Langaee and Dr. Steven Smith|
|Genetic biomarkers for personalized drug therapy||Dr. Danxin Wang|
|Predictors of health disparities and implementation of intervention programs in minority and underserved communities||Dr. Folakemi Odedina|
|Infectious disease, therapeutic drug monitoring and clinical trials for patients with advanced mycobacterial diseases||Dr. Charles Peloquin|
Bacterial ‘superbugs’ which are resistant to most or all antibiotics present one of the three most serious threats to human health in the US and worldwide. To combat this substantial global health crisis, the dynamic antimicrobial research team at Lake Nona is developing innovative antibiotic combination therapies which can successfully treat infections by these ‘superbugs.’ This team is headed by Dr. Jürgen Bulitta who is an internationally recognized expert in antimicrobial pharmacology, latest in vitro infection models, and translational mechanistic modeling.